PROTOX THERAPEUTICS INC — Form D
PROTOX THERAPEUTICS INC of Vancouver, A1, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-15. The offering totals $404K, of which $226K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-04-15
- Form: D
- Accession: 0001140361-10-016600
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $404K
- Amount sold: $226K
- Remaining: $178K
- Investors: 3
- Date of first sale: 2010-03-16
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-140657
Issuer
- Name: PROTOX THERAPEUTICS INC
- CIK: 0001384825
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 885 West Georgia Street - Suite 1210, Vancouver, A1, V6C 3E8
- Phone: 604-608-4211
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Samuel Denmeade | Executive Officer | Vancouver, A1 |
| James Miller | Director | PONTE VEDRA, FL |
| Fahar Merchant | Director | Toronto, A6 |
| Fahar Merchant | Executive Officer | Toronto, A6 |
| Jim Heppell | Director | Vancouver, A1 |
| John Parkinson | Executive Officer | Victoria, A1 |
| Avtar Dhillon | Director | San Diego, CA |
| Frank Holler | Director | Vancouver, A1 |
| Jack Geltosky | Director | Vancouver, A1 |
| Alexander Giaquinto | Director | Vancouver, A1 |
| Tom D'Orazio | Executive Officer | Vancouver, A1 |
| Nina Merchant | Executive Officer | Vancouver, A1 |
Other filings by this issuer (1)
More